1. Home
  2. WTBA vs ACIU Comparison

WTBA vs ACIU Comparison

Compare WTBA & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WTBA

West Bancorporation

N/A

Current Price

$29.71

Market Cap

488.6M

Sector

Finance

ML Signal

N/A

Logo AC Immune SA

ACIU

AC Immune SA

N/A

Current Price

$2.68

Market Cap

247.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WTBA
ACIU
Founded
1893
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
488.6M
247.6M
IPO Year
2002
2015

Fundamental Metrics

Financial Performance
Metric
WTBA
ACIU
Price
$29.71
$2.68
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$24.00
$10.00
AVG Volume (30 Days)
45.4K
180.6K
Earning Date
04-23-2026
05-12-2026
Dividend Yield
4.17%
N/A
EPS Growth
35.21
N/A
EPS
1.26
N/A
Revenue
N/A
N/A
Revenue This Year
$23.80
$706.75
Revenue Next Year
$9.39
$321.13
P/E Ratio
$23.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.03
$2.10
52 Week High
$30.33
$4.00

Technical Indicators

Market Signals
Indicator
WTBA
ACIU
Relative Strength Index (RSI) 62.33 49.62
Support Level $25.77 $2.57
Resistance Level $30.33 $2.68
Average True Range (ATR) 0.49 0.13
MACD 0.03 -0.02
Stochastic Oscillator 80.10 19.05

Price Performance

Historical Comparison
WTBA
ACIU

About WTBA West Bancorporation

West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings, and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America.

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: